FK 866 hydrochloride
Tocris Bioscience | Catalog # 4808
Key Product Details
Description
Product Description
FK 866 hydrochloride is a non-competitive and potent inhibitor of NAMPT (nicotinamide phosphoribosyltransferase, PBEF1) (Ki = 0.3 nM); inhibits NAD biosynthesis. Induces delayed cell death by apoptosis in HepG2 human liver carcinoma cells (IC50 ~1 nM). Induces apoptosis in four different neuroblastoma cell lines; also induces autophagy in SH-SY5Y cells. Potentiates the cytotoxic effects induced by etoposide (Cat. No. 1226) and cisplatin (Cat. No. 2251).
Product Specifications for FK 866 hydrochloride
Molecular Weight
Formula
Storage
Purity
Chemical Name
CAS Number
PubChem ID
InChI Key
SMILES
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| water | 2.14 | 5 with gentle warming | |
| DMSO | 42.8 | 100 |
Preparing Stock Solutions for FK 866 hydrochloride
The following data is based on the product molecular weight 427.97.
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 2.34 mL | 11.68 mL | 23.37 mL |
| 5 mM | 0.47 mL | 2.34 mL | 4.67 mL |
| 10 mM | 0.23 mL | 1.17 mL | 2.34 mL |
| 50 mM | 0.05 mL | 0.23 mL | 0.47 mL |
Calculators
Background References
References are publications that support the biological activity of the product. See our Citations tab to view 6 publications citing the usage of this product.
- Hasmann FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Res. 2003 PMID: 14612543
- Galli Synthesis and biological evaluation of isosteric analogues of FK866, an inhibitor of NAD salvage. ChemMedChem 2008 PMID: 18247435
- Travelli Reciprocal potentiation of the antitumoral activities of FK866, an inhibitor of nicotinamide phosphoribosyltransferase, and etop. or cisp. in neuroblastoma cells. J.Pharmacol.Exp.Ther. 2011 PMID: 21685314
Product Documents for FK 866 hydrochloride
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Product Specific Notices for FK 866 hydrochloride
For research use only
Related Research Areas
Citations for FK 866 hydrochloride
Customer Reviews for FK 866 hydrochloride (1)
Have you used FK 866 hydrochloride?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Customer Images
-
Species: HumanAssay Type: In VitroCell Line/Tissue: Cancer and liver cell linesVerified Customer | Posted 04/07/2022Inhibition of NAD in cancer cells requires 3-4 days of treatmentFK866 Inhibits NAD+ production and NAMPT activity in cancer cells.
There are no reviews that match your criteria.